When examining the subgroup of patients older than 65 years of age (n = 21), there were significant increases in hematocrit (mean, 32.8% versus 28.1%) and lowering of the erythropoietin dose (mean, 92.8 versus 141.3 U/kg) in the L-carnitine-treated patients compared with placebo-treated controls
Strategies to mitigate these effects include starting with a low dose and gradually increasing it, allowing the patients body to adjust to the medication
[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Scirica BM, Lincoff AM, Lingvay I, et al
Most patients experience mild side effects like nausea, bloating, or constipation, which typically ease over time
To work effectively, it has to be titrated that means starting at a low dose and gradually increasing it based on how your body responds
These options are listed for information only your own clinician decides what is appropriate for you